415 related articles for article (PubMed ID: 16635348)
21. Number and size of lymph nodes recovered from dukes B rectal cancers: correlation with prognosis and histologic antitumor immune response.
Murphy J; Pocard M; Jass JR; O'Sullivan GC; Lee G; Talbot IC
Dis Colon Rectum; 2007 Oct; 50(10):1526-34. PubMed ID: 17828403
[TBL] [Abstract][Full Text] [Related]
22. [Clinical significance of detection on lymphatic microvessel, lymphatic microvessel density and vascular endothelial growth factor-C in patients with colorectal carcinoma].
Fan YZ; Li GM; Huang GP; Li XP
Zhonghua Wei Chang Wai Ke Za Zhi; 2006 Nov; 9(6):477-82. PubMed ID: 17143789
[TBL] [Abstract][Full Text] [Related]
23. Evidence for colorectal cancer micrometastases using reverse transcriptase-polymerase chain reaction analysis of MUC2 in lymph nodes.
Bernini A; Spencer M; Frizelle S; Madoff RD; Willmott LD; McCormick SR; Niehans GA; Ho SB; Kratzke RA
Cancer Detect Prev; 2000; 24(1):72-9. PubMed ID: 10757125
[TBL] [Abstract][Full Text] [Related]
24. Gelatinase B expression as a prognostic factor in patients with stage II/III rectal carcinoma treated by postoperative adjuvant therapy.
Unsal D; Akyurek N; Uner A; Erpolat OP; Han U; Akmansu M; Mentes BB; Dursun A
Am J Clin Oncol; 2008 Feb; 31(1):55-63. PubMed ID: 18376229
[TBL] [Abstract][Full Text] [Related]
25. Improvement of 10-year survival by Japanese radical lymph node dissection in patients with Dukes' B and C colorectal cancer: a 17-year retrospective study.
Mukai M; Ito I; Mukoyama S; Tajima T; Saito Y; Nakasaki H; Sato S; Makuuchi H
Oncol Rep; 2003; 10(4):927-34. PubMed ID: 12792747
[TBL] [Abstract][Full Text] [Related]
26. Nm23-H1 expression does not predict clinical survival in colorectal cancer patients.
Dusonchet L; Corsale S; Migliavacca M; Calò V; Bazan V; Amato A; Cammareri P; Totaro MS; Agnese V; Cascio S; La Rocca G; Sisto PS; Dardanoni G; Valerio MR; Grassi N; Latteri S; Cajozzo M; Buscemi M; Castorina S; Morello V; Tomasino RM; Gebbia N; Russo A
Oncol Rep; 2003; 10(5):1257-63. PubMed ID: 12883690
[TBL] [Abstract][Full Text] [Related]
27. Expression of nm23-H1 gene product in sarcomatous cancer cells of renal cell carcinoma: correlation with tumor stage and expression of matrix metalloproteinase-2, matrix metalloproteinase-9, sialyl Lewis X, and c-erbB-2.
Ohba K; Miyata Y; Koga S; Kanda S; Kanetake H
Urology; 2005 May; 65(5):1029-34. PubMed ID: 15882758
[TBL] [Abstract][Full Text] [Related]
28. Matrix metalloproteinase/tissue inhibitors of matrix metalloproteinase phenotype identifies poor prognosis colorectal cancers.
Curran S; Dundas SR; Buxton J; Leeman MF; Ramsay R; Murray GI
Clin Cancer Res; 2004 Dec; 10(24):8229-34. PubMed ID: 15623598
[TBL] [Abstract][Full Text] [Related]
29. Predictive value of lymph node and tumor matrix metalloproteinase expression in the analysis of metastatic periampullary tumors.
McKenna GJ; Meneghetti A; Chen YL; Mui AL; Ong C; Scudamore CH; McMaster WR; Owen DA; Chung SW
J Surg Oncol; 2005 Jun; 90(4):239-46. PubMed ID: 15906368
[TBL] [Abstract][Full Text] [Related]
30. [Angiogenesis and the expression of nm23-H(1) tumor metastatic suppressor gene in primary breast carcinoma and their relations to lymph node metastasis].
Li Y; Wu F; Gong W
Zhonghua Wai Ke Za Zhi; 2002 Mar; 40(3):177-9. PubMed ID: 11955409
[TBL] [Abstract][Full Text] [Related]
31. Sentinel node mapping and micrometastasis in patients with clinical stage IA non-small cell lung cancer.
Ono T; Minamiya Y; Ito M; Saito H; Motoyama S; Nanjo H; Ogawa J
Interact Cardiovasc Thorac Surg; 2009 Oct; 9(4):659-61. PubMed ID: 19643803
[TBL] [Abstract][Full Text] [Related]
32. Topoisomerase I protein expression in primary colorectal cancer and lymph node metastases.
Boonsong A; Curran S; McKay JA; Cassidy J; Murray GI; McLeod HL
Hum Pathol; 2002 Nov; 33(11):1114-9. PubMed ID: 12454816
[TBL] [Abstract][Full Text] [Related]
33. Correlates of urokinase-type plasminogen activator in colorectal cancer: positive relationship with nm23 and c-erbB-2 protein expression.
Berney CR; Yang J; Fisher RJ; Russell PJ; Crowe PJ
Oncol Res; 1998; 10(1):47-54. PubMed ID: 9613457
[TBL] [Abstract][Full Text] [Related]
34. [Expression of metallothionein and FasL in colorectal cancer and its clinical significance].
Li SY; Yu B; An P; Zuo FY; Cai HY
Zhonghua Wai Ke Za Zhi; 2005 Sep; 43(17):1118-20. PubMed ID: 16194308
[TBL] [Abstract][Full Text] [Related]
35. Clinical significance of nm23 gene expression in gastric cancer.
Mönig SP; Nolden B; Lübke T; Pohl A; Grass G; Schneider PM; Dienes HP; Hölscher AH; Baldus SE
Anticancer Res; 2007; 27(4C):3029-33. PubMed ID: 17695492
[TBL] [Abstract][Full Text] [Related]
36. Correlation between occult neoplastic cells in the lymph node sinuses and recurrence in patients with curatively resected Dukes' B colorectal cancer.
Mukai M; Sato S; Komatsu N; Nishida T; Shiba K; Ito I; Nakasaki H; Makuuchi H
Oncol Rep; 2003; 10(5):1177-81. PubMed ID: 12883677
[TBL] [Abstract][Full Text] [Related]
37. The prognostic significance of immunohistochemically detected lymph node micrometastases in colorectal carcinoma.
Jeffers MD; O'Dowd GM; Mulcahy H; Stagg M; O'Donoghue DP; Toner M
J Pathol; 1994 Feb; 172(2):183-7. PubMed ID: 7513353
[TBL] [Abstract][Full Text] [Related]
38. Allelic imbalance at NME1 in microdissected primary and metastatic human colorectal carcinomas is frequent but not associated with metastasis to lymph nodes or liver.
Lamb RF; Going JJ; Pickford I; Birnie GD
Cancer Res; 1996 Feb; 56(4):916-20. PubMed ID: 8631033
[TBL] [Abstract][Full Text] [Related]
39. Nm23 'anti-metastatic' gene product expression in colorectal carcinoma.
Royds JA; Cross SS; Silcocks PB; Scholefield JH; Rees RC; Stephenson TJ
J Pathol; 1994 Mar; 172(3):261-6. PubMed ID: 8195929
[TBL] [Abstract][Full Text] [Related]
40. Selection criteria for high risk and low risk groups of recurrence and metastasis in patients with primary colorectal cancer.
Mukai M; Sato S; Nishida T; Komatsu N; Shiba K; Nakasaki H; Makuuchi H
Oncol Rep; 2003; 10(6):1753-8. PubMed ID: 14534691
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
